#vaccine #prevent #malaria #ready #tested #humans
2024-04-04 09:42:00
This is a full-fledged malaria parasite vaccine strain that infects the liver, develops to the late liver stage, and then becomes completely stuck and cannot leave the liver to cause a symptomatic blood infection.
A group of researchers from the Seattle Children’s Research Institute (USA) and the company Sanaria have developed a new vaccine to prevent malaria and which is now available to be tested in humans, as reported in a report published on December 21. March 2024… + read more
They explore a potential new treatment for liver cancer
Its activity in a preclinical model suggests that preventing hypoxia-induced metabolic reprogramming limits tumor cell viability.
Exenatide outperforms other antidiabetics in patients with non-alcoholic fatty liver
The results of a voluminous study indicate that the drug offers excellent potential in reducing liver fat content, in addition to good control over other parameters related to diabetes.
Having a fatty liver multiplies the risk of liver cancer by up to 3
Obesity and diabetes are factors that increase the incidence of fatty liver, a pathology suffered by 1 in every four Spaniards, and which can lead to cirrhosis and, in other cases, liver cancer.
+ read more
Treat liver cancer with microrobots piloted by a magnetic field
Guided by an external magnetic field, miniature biocompatible robots, made from magnetizable iron oxide nanoparticles, can theoretically deliver medical treatments in a highly targeted manner.
+ read more
Obesity, a risk factor for developing liver cancer
Blocking the stress that excess fat causes in cells may be a way against liver cancer.
+ read more
Surgical innovation improves the approach to liver cancer
Hepatocellular carcinoma is the most common liver cancer: between 60% and 90% of cases are associated with cirrhosis.
+ read more
